B

BMP Pharma Trading AG
XBER:BMP

Watchlist Manager
BMP Pharma Trading AG
XBER:BMP
Watchlist
Price: 5.3 EUR Market Closed
Market Cap: €27.8m

Balance Sheet

Balance Sheet Decomposition
BMP Pharma Trading AG

Balance Sheet
BMP Pharma Trading AG

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
12
11
9
2
1
0
0
0
0
0
0
1
1
1
2
2
2
2
2
5
7
8
Accounts Receivables
12
11
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
2
1
0
0
0
0
0
0
1
1
0
2
2
2
0
2
5
0
0
Inventory
4
3
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
2
2
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
17
17
16
2
1
1
0
0
1
1
0
1
1
2
2
2
2
3
2
5
7
8
PP&E Net
2
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
2
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
5
5
5
5
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
21
N/A
24
+13%
22
-7%
6
-72%
5
-17%
5
-9%
4
-6%
4
-1%
5
+7%
4
-5%
5
+2%
5
+8%
5
+0%
5
+10%
5
+2%
6
+1%
6
+8%
6
+6%
7
+8%
10
+42%
12
+22%
13
+8%
Liabilities
Accounts Payable
4
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accrued Liabilities
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
9
8
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
Other Current Liabilities
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
13
14
13
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
1
1
0
0
Long-Term Debt
1
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
Total Liabilities
15
N/A
19
+28%
18
-7%
0
-100%
0
N/A
1
+1 300%
1
+1%
1
-7%
1
-41%
0
-69%
0
-21%
0
+27%
0
-16%
0
+53%
0
+36%
0
+17%
0
+3%
0
+15%
1
+80%
1
+46%
3
+184%
4
+31%
Equity
Common Stock
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Retained Earnings
1
0
0
1
0
2
2
2
1
1
1
1
0
0
0
0
0
1
1
3
3
4
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
6
N/A
4
-24%
4
-3%
6
+43%
5
-17%
4
-30%
3
-9%
3
+1%
4
+22%
4
+5%
4
+3%
5
+7%
5
+1%
5
+8%
5
0%
5
+0%
6
+9%
6
+6%
6
+3%
9
+41%
9
+1%
9
+3%
Total Liabilities & Equity
21
N/A
24
+13%
22
-7%
6
-72%
5
-17%
5
-9%
4
-6%
4
-1%
5
+7%
4
-5%
5
+2%
5
+8%
5
+0%
5
+10%
5
+2%
6
+1%
6
+8%
6
+6%
7
+8%
10
+42%
12
+22%
13
+8%
Shares Outstanding
Common Shares Outstanding
2
2
2
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett